CMECME Group
$305.71+20% 1Y
$305.71
$218.5552 weeks$317.19
CME as reported
CME Group reported $6.77B of revenue over the trailing twelve months, +5.1% on the year before. 10 reported series are charted on this page, each one as filed.
$6.77B
Revenue, trailing twelve months · to Q2 2026 · +5.1% against the twelve months before
- Net income
- $4.29B
Net income · +14% year on year · trailing twelve months to Q2 2026
- Free cash flow
- $4.21B
Free cash flow · +2.6% year on year · trailing twelve months to Q2 2026
- Operating margin
- 65%
Operating margin · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $6.77B | +5.1% | Q2 2026 |
| Net income | $4.29B | +14% | Q2 2026 |
| EPS | $11.79 | +14% | Q2 2026 |
| Operating margin | 65% | n/a | Q2 2026 |
| Net margin | 63% | n/a | Q2 2026 |
| ROE | 15% | n/a | Q2 2026 |
| ROA | 2.1% | n/a | Q2 2026 |
| ROIC | 12% | n/a | Q2 2026 |
| Free cash flow | $4.21B | +2.6% | Q2 2026 |
| P/E | 25.9 | n/a | today |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

CME Group (CME) · Revenue and profitRevenue and profitCME Group (CME)
RevenueNet incomeTrailing twelve months
Powered byryufin.com